These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 16364973

  • 1. Aspirin and clopidogrel resistance: an emerging clinical entity.
    Wang TH, Bhatt DL, Topol EJ.
    Eur Heart J; 2006 Mar; 27(6):647-54. PubMed ID: 16364973
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aspirin resistance or variable response or both?
    Cheng X, Chen WH, Simon DI.
    Am J Cardiol; 2006 Nov 20; 98(10A):11N-17N. PubMed ID: 17097412
    [Abstract] [Full Text] [Related]

  • 7. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 20; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS.
    Int J Clin Pract; 2007 Oct 20; 61(10):1739-48. PubMed ID: 17877660
    [Abstract] [Full Text] [Related]

  • 13. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.
    Siller-Matula J, Schrör K, Wojta J, Huber K.
    Thromb Haemost; 2007 Mar 20; 97(3):385-93. PubMed ID: 17334505
    [Abstract] [Full Text] [Related]

  • 14. Aspirin and clopidogrel resistance.
    Michos ED, Ardehali R, Blumenthal RS, Lange RA, Ardehali H.
    Mayo Clin Proc; 2006 Apr 20; 81(4):518-26. PubMed ID: 16610572
    [Abstract] [Full Text] [Related]

  • 15. Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.
    Spinler SA.
    Pharmacotherapy; 2009 Jul 20; 29(7):812-21. PubMed ID: 19558255
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clopidogrel response variability, resistance, or both?
    Wiviott SD.
    Am J Cardiol; 2006 Nov 20; 98(10A):18N-24N. PubMed ID: 17097413
    [Abstract] [Full Text] [Related]

  • 20. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
    Lepäntalo A, Virtanen KS, Reséndiz JC, Mikkelsson J, Viiri LE, Karhunen PJ, Lassila R.
    Thromb Res; 2009 Jun 20; 124(2):193-8. PubMed ID: 19232433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.